Skip to Main Content

Paper Details

Aurora A kinase as a target for therapy in <i>TCF3-HLF</i> rearranged acute lymphoblastic leukemia.
Haematologica
4
2021
Aurora A kinase, HLF, TCF3
Author NameAffiliation
Jessica LeonardDepartment of Medicine and OHSU Knight Cancer Institute. OHSU
Joelle WolfDepartment of Pediatrics and OHSU Knight Cancer Institute. OHSU
Michelle DegninDepartment of Medicine and OHSU Knight Cancer Institute. OHSU
Christopher A EideDepartment of Medicine and OHSU Knight Cancer Institute. OHSU
Dorian LaTochaDepartment of Medicine and OHSU Knight Cancer Institute. OHSU
Beth WilmotDepartment of Medical Informatics and Clinical Epidemiology, and OHSU Knight Cancer Institute
Charles G MullighanSt Jude Children's Research Hospital and University of Tennessee Health Science Center
Mignon L LohBenioff Children's Hospital, Helen Diller Family Comprehensive Cancer Center, University of California san francisco
Stephen P HungerDepartment of Pediatrics and the Center for Childhood Cancer Research, Children's Hospital of Philadelphia and the Perelman School of Medicine at the University of Pennsylvania, Children's Hospital of Philadelphia.
Stephen P HungerDepartment of Pediatrics and the Center for Childhood Cancer Research, Children's Hospital of Philadelphia and the Perelman School of Medicine at the University of Pennsylvania, Children's Hospital of Philadelphia.
Brian J DrukerDepartment of Medicine and OHSU Knight Cancer Institute. OHSU, Howard Hughes Medical Institute.
Marc M LoriauxDepartment of Pathology and OHSU Knight Cancer Institute. OHSU
Jeffrey W TynerDepartment of Medicine and OHSU Knight Cancer Institute. OHSU, and OHSU Knight Cancer Institute
Bill H ChangDepartment of Pediatrics and OHSU Knight Cancer Institute. OHSU
  • 1 - 14

Datasets